Search Results 751-760 of 16858 for CLL

  1. Chemotherapy - Doctors & Departments - Mayo Clinic

    Chemotherapy side effects: A cause of heart disease? Chondrosarcoma · Choroid plexus carcinoma · Chronic lymphocytic leukemia · Colon cancer · Cutaneous T-cell ...

  2. Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma - Mayo Clinic

    About this study. This phase II trial studies how well nivolumab works in treating patients with peripheral T-cell lymphoma that has come back after a ...

  3. Lung cancer care advancements in the American Southwest - Mayo Clinic

    Mayo Clinic experts have transformed clinical care for patients with lung cancer. With more screening options and less invasive surgical options, ...

  4. Childhood Cancer Archives - Mayo Clinic News Network

  5. Publications - Muhamad Alhaj Moustafa, M.D., M.S. - Mayo Clinic

    90Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases. Blood Lymphat ...

  6. Cutaneous T-cell lymphoma - Care at Mayo Clinic

    Learn about this type of non-Hodgkin lymphoma that attacks the skin. Find out about symptoms, diagnosis and treatments.

  7. Colon cancer - Doctors and departments - Mayo Clinic

    Find out about symptoms and causes for this cancer that starts in the large intestine. Learn about treatment options, including minimally invasive surgery.

  8. CDC reports variant of swine flu not seen previously in people

    Living With Cancer: Chronic lymphocytic leukemia. Related Articles. Featured News. Willis Knighton Health in Louisiana joins Mayo Clinic Care Network. Health ...

  9. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  10. Recruitment/Treatment of Minority Patients on Cancer Trials at Mayo Clinic

    About this study. The short-term goal of this study is to inform the process and mechanisms to enrich URM patient accrual to interventional cancer treatment ...